This video makes reference to guidelines produced by the "National Institute for Health and Care Excellence" in the UK, also referred to as "NICE". Please note that the content on this channel reflects my professional interpretation/summary of the guidance and that I am in no way affiliated with, employed by or funded/sponsored by NICE. My name is Fernando Florido and I am a GP in the United Kingdom. In today’s episode I review the NICE guidance on inhalers, both for asthma and COPD. I have summarised the guidance from a Primary Care perspective and I have put the links to that guidance below. By way of disclaimer, I am not giving medical advice; this video is intended for health care professionals, it is only my interpretation of the guidelines and you must use your clinical judgement. Tracks: 00:00 - Introduction, welcome and disclaimer 01:30 – Inhaled corticosteroids 07:20 – Inhaled beta 2 agonists 11:35 – Inhaled antimuscarinics 14:56 – Combination inhalers 18:28 - Conclusion, thank you and good-bye There is a podcast version of this and other videos that you can access here: Primary Care guidelines podcast: • Redcircle: • Spotify: • Apple podcasts: The following NICE guidance can be found here: • Asthma Inhaled corticosteroids- Last revised in April 2022: • Asthma: Beta2 agonists- Last revised in April 2022: • Chronic obstructive pulmonary disease: Inhaled corticosteroids- Last revised in June 2023: • Chronic obstructive pulmonary disease: Muscarinic antagonists- Last revised in June 2023: • Chronic obstructive pulmonary disease: Beta-2 agonists- Last revised in June 2023: • Corticosteroids - inhaled: Scenario: Corticosteroids – inhaled- Last revised in May 2020: #choosing-a-delivery-system • Corticosteroids – inhaled- Last revised in May 2020: • Corticosteroids - inhaled: Which inhaled corticosteroids are available in the UK?- Last revised in May 2020: